The role of cardiopulmonary exercise test in IPF prognosis

Pulmonary Medicine

Volumn , Issue , 2013, Pages

  Triantafillidou, Christina ^a,b   Manali, Effrosyni ^a   Lyberopoulos, Panagiotis ^a   Kolilekas, Likourgos ^a,b   Kagouridis, Konstantinos ^a   Gyftopoulos, Sotirios ^a   Vougas, Konstantinos ^c   Kotanidou, Anastasia ^d   Alchanatis, Manos ^d   Karakatsani, Anna ^a   Papiris, Spyros A ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAEROBIC THRESHOLD; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID DESATURATION; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; LUNG MINUTE VOLUME; MALE; MORTALITY; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SIX MINUTE WALK TEST; SURVIVAL; TOTAL LUNG CAPACITY;

EID: 84888872392     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2013/514817     Document Type: Article

References (35)

1. Raghu G., Collard H. R., Egan J. J., Martinez F. J., Behr J., Brown K. K., Colby T. V., Cordier J. F., Flaherty K. R., Lasky J. A., Lynch D. A., Ryu J. H., Swigris J. J., Wells A. U., Ancochea J., Bouros D., Carvalho C., Costabel U., Ebina M., Hansell D. M., Johkoh T., Kim D. S., King T. E. Jr., Kondoh Y., Myers J., Müller N. L., Nicholson A. G., Richeldi L., Selman M., Dudden R. F., Griss B. S., Protzko S. L., Schünemann H. J., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 2011 183 6 788 824 2-s2.0-79952717349 10.1164/rccm.2009-040GL
2. Ley B., Collard H. R., King T. E. Jr., Clinical course and prediction of survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2011 183 4 431 440 2-s2.0-79951844263 10.1164/rccm.201006-0894CI
3. Barlo N. P., van Moorsel C. H. M., van den Bosch J. M. M., Grutters J. C., Predicting prognosis in idiopathic pulmonary fibrosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2010 27 2 85 95 2-s2.0-78651304303
4. Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Kato K., Kataoka K., Ogawa T., Watanabe F., Arizono S., A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. European Respiratory Journal 2010 36 5 1067 1072 2-s2.0-78349286777 10.1183/09031936.00152609
5. Patel N. M., Lederer D. J., Borczuk A. C., Kawut S. M., Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007 132 3 998 1006 2-s2.0-35449003614 10.1378/chest.06-3087
6. Mejía M., Carrillo G., Rojas-Serrano J., Estrada A., Suárez T., Alonso D., Barrientos E., Gaxiola M., Navarro C., Selman M., Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009 136 1 10 15 2-s2.0-67650786507 10.1378/chest.08-2306
7. Manali E. D., Stathopoulos G. T., Kollintza A., Kalomenidis I., Emili J. M., Sotiropoulou C., Daniil Z., Roussos C., Papiris S. A., The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respiratory Medicine 2008 102 4 586 592 2-s2.0-40049106662 10.1016/j.rmed.2007.11.008
8. Lynch D. A., Godwin J. D., Safrin S., Starko K. M., Hormel P., Brown K. K., Raghu G., King T. E. Jr., Bradford W. Z., Schwartz D. A., Webb W. R., High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. American Journal of Respiratory and Critical Care Medicine 2005 172 4 488 493 2-s2.0-23644440296 10.1164/rccm.200412-1756OC (Pubitemid 41117395)
9. Triantafillidou C., Manali E. D., Magkou C., Sotiropoulou C., Kolilekas L. F., Kagouridis K., Rontogianni D., Papiris S. A., Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF. Diagnostic Pathology 2011 6 1, article 28 2-s2.0-79953289205 10.1186/1746-1596-6-28
10. Nicholson A. G., Fulford L. G., Colby T. V., Du Bois R. M., Hansell D. M., Wells A. U., The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2002 166 2 173 177 2-s2.0-0037099161 10.1164/rccm.2109039 (Pubitemid 34765453)
11. Collard H. R., King T. E. Jr., Bartelson B. B., Vourlekis J. S., Schwarz M. I., Brown K. K., Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2003 168 5 538 542 2-s2.0-0041874992 10.1164/rccm.200211- 1311OC (Pubitemid 37088595)
12. King T. E. Jr., Tooze J. A., Schwarz M. I., Brown K. R., Cherniack R. M., Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. American Journal of Respiratory and Critical Care Medicine 2001 164 7 1171 1181 2-s2.0-0035482002 (Pubitemid 33052246)
13. Manali E. D., Lyberopoulos P., Triantafillidou C., Kolilekas L. F., Sotiropoulou C., Milic-Emili J., Roussos C., Papiris S. A., MRC chronic dyspnea scale: relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study. BMC Pulmonary Medicine 2010 10 article 32 2-s2.0-77952734061 10.1186/1471-2466-10-32
14. Swigris J. J., Kuschner W. G., Jacobs S. S., Wilson S. R., Gould M. K., Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005 60 7 588 594 2-s2.0-22044432630 10.1136/thx.2004.035220 (Pubitemid 40966214)
15. Wells A. U., Hirani N., Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008 63 supplement 5 v1 v58 2-s2.0-51549101867 10.1136/thx.2008.101691
16. Eaton T., Young P., Milne D., Wells A. U., Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. American Journal of Respiratory and Critical Care Medicine 2005 171 10 1150 1157 2-s2.0-18644363812 10.1164/rccm.200405-578OC (Pubitemid 40663728)
17. Lama V. N., Flaherty K. R., Toews G. B., Colby T. V., Travis W. D., Long Q., Murray S., Kazerooni E. A., Gross B. H., Lynch J. P. III, Martinez F. J., Prognostic value of desaturation during a 6 minute walk test in idiopathic interstitial pneumonia. American Journal of Respiratory and Critical Care Medicine 2003 168 9 1084 1090 2-s2.0-10744229010 10.1164/rccm.200302-219OC (Pubitemid 37338937)
18. Lederer D. J., Arcasoy S. M., Wilt J. S., D'Ovidio F., Sonett J. R., Kawut S. M., Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2006 174 6 659 664 2-s2.0-33748688190 10.1164/rccm.200604-520OC (Pubitemid 44395333)
19. ATS/ACCP Statement of cardiopulmonary testing. American Journal of Respiratory and Critical Care Medicine 2003 167 2 211 277
20. American Thoracic Society, European Respiratory Society, American College of Chest Physicians, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Journal of Respiratory and Critical Care Medicine 2000 161 2 646 664 10.1164/ajrccm.161.2.ats3-00
21. Crapo R. O., Casaburi R., Coates A. L., Enright P. L., MacIntyre N. R., McKay R. T., Johnson D., Wanger J. S., Zeballos R. J., Bittner V., Mottram C., ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002 166 1 111 117 2-s2.0-0036644465 (Pubitemid 34693972)
22. Schwarz G., Estimating the dimension of a model. Annals of Statistics 1978 6 2 461 464
23. Fell C. D., Liu L. X., Motika C., Kazerooni E. A., Gross B. H., Travis W. D., Colby T. V., Murray S., Toews G. B., Martinez F. J., Flaherty K. R., The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2009 179 5 402 407 2-s2.0-63349091740 10.1164/rccm.200802-241OC
24. Wallaert B., Guetta A., Wemeau-Stervinou L., Tercé G., Valette M., Nevière R., Aguilaniu B., Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis. Revue des Maladies Respiratoires 2011 28 3, article 257 290 296 2-s2.0-79959515597 10.1016/j.rmr.2010.08.016
25. Gay S. E., Kazerooni E. A., Toews G. B., Lynch J. P. III, Gross B. H., Cascade P. N., Spizarny D. L., Flint A., Schork M. A., Whyte R. I., Popovich J., Hyzy R., Martinez F. J., Idiopathic pulmonary fibrosis: predicting response to therapy and survival. American Journal of Respiratory and Critical Care Medicine 1998 157 4 1063 1072 2-s2.0-0031980108
26. Erbes R., Schaberg T., Loddenkemper R., Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome? Chest 1997 111 1 51 57 2-s2.0-0031020880 (Pubitemid 27043606)
27. Balady G. J., Arena R., Sietsema K., Myers J., Coke L., Fletcher G. F., Forman D., Franklin B., Guazzi M., Gulati M., Keteyian S. J., Lavie C. J., MacKo R., Mancini D., Milani R. V., Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American heart association. Circulation 2010 122 2 191 225 2-s2.0-77954760052 10.1161/CIR.0b013e3181e52e69
28. 2 in systolic heart failure: a meta-analysis of the published literature. American Heart Journal 2010 160 6 1004 1014 2-s2.0-78650109013 10.1016/j.ahj.2010.08.037
29. 2 maximum work rate, and walking distance in patients with emphysema. Chest 2003 123 5 1394 1400 2-s2.0-0037541116 10.1378/chest.123.5.1394 (Pubitemid 36549755)
30. Celli B. R., Cote C. G., Marin J. M., Casanova C., Montes De Oca M., Mendez R. A., Plata V. P., Cabral H. J., The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New England Journal of Medicine 2004 350 10 1005 1012 2-s2.0-1442306237 10.1056/NEJMoa021322 (Pubitemid 38269277)
31. Ley B., Ryerson C., Vittinghoff E., Ryu J., Tomassetti S., Lee V Poletti J., Buccioli M., Elicker B., Jones K., King T., Collard H., A multidimensional index and staging system for idiopathic pulmonary fibrosis. Annals of Internal Medicine 2012 156 10 684 691
32. Wells A. U., Desai S. R., Rubens M. B., Goh N. S. L., Cramer D., Nicholson A. G., Colby T. V., Du Bois R. M., Hansell D. M., Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. American Journal of Respiratory and Critical Care Medicine 2003 167 7 962 969 2-s2.0-0037383987 10.1164/rccm.2111053 (Pubitemid 36408161)
33. Flaherty K. R., Andrei A. C., Murray S., Fraley C., Colby T. V., Travis W. D., Lama V., Kazerooni E. A., Gross B. H., Toews G. B., Martinez F. J., Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. American Journal of Respiratory and Critical Care Medicine 2006 174 7 803 809 2-s2.0-33749434364 10.1164/rccm.200604-488OC (Pubitemid 44511662)
34. 'Donnell D. E. O., Ofir D., Laveneziana P., Patterns of cardiopulmonary response to exercise in lung diseases. European Respiratory Monograph 2007 40 69 92
35. Karakatsani A., Papakosta D., Rapti A., Antoniou K. M., Dimadi M., Markopoulou A., Latsi P., Polychronopoulos V., Birba G., Ch L., Bouros D., Epidemiology of interstitial lung diseases in Greece. Respiratory Medicine 2009 103 8 1122 1129 2-s2.0-67649195440 10.1016/j.rmed.2009.03.001